half the stuff currently in clinical trials is not targeting amyloids. https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70098 https://alz-journals

half the stuff currently in clinical trials is not targeting amyloids. https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70098 https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc...